Source | hl7.fhir.uv.emedicinal-product-info#current:Electronic Medicinal Product Information (ePI) FHIR Implementation Guide (v5.0.0) |
resourceType | StructureDefinition |
id | MedicinalProductDefinition-uv-epi |
canonical | http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi |
version | 1.0.0 |
status | active |
publisher | HL7 International - Biomedical Research & Regulation Work Group |
name | MedicinalProductDefinitionUvEpi |
title | MedicinalProductDefinition (ePI) |
date | 2023-06-14T14:00:01+00:00 |
description | Description of the packaged authorized medicinal product(s) associated to this ePI document. |
jurisdictions | uv |
fhirVersion | 5.0.0 |
kind | resource |
abstract | false |
sdTtype | MedicinalProductDefinition |
derivation | constraint |
base | http://hl7.org/fhir/StructureDefinition/MedicinalProductDefinition |
Usages |
|
Name | Flags | Card. | Type |
Description & Constraints
![]() |
---|---|---|---|---|
![]() ![]() |
MedicinalProductDefinition | |||
![]() ![]() ![]() |
1.. | |||
![]() ![]() ![]() ![]() |
1.. | |||
![]() ![]() ![]() ![]() |
1.. | |||
![]() ![]() ![]() |
Regulatory type, e.g. Investigational or Authorized. | |||
![]() ![]() ![]() |
If this medicine applies to human or veterinary uses. Binding: Medicinal Product Domain ( example ) |
|||
![]() ![]() ![]() |
A business identifier relating to a specific version of the product. | |||
![]() ![]() ![]() |
The status within the lifecycle of this product record. | |||
![]() ![]() ![]() |
The date at which this status became applicable. | |||
![]() ![]() ![]() |
General description of the medicinal product referred by the ePI | |||
![]() ![]() ![]() |
Binding: Dose Form ( example ) | |||
![]() ![]() ![]() |
Binding: Route Of Administration ( example ) | |||
![]() ![]() ![]() |
Narrative text of the authorized indication(s) for this product. | |||
![]() ![]() ![]() |
The legal status of supply of the medicinal product as classified by the regulator. | |||
![]() ![]() ![]() |
Whether the Medicinal Product is subject to additional monitoring for regulatory reasons. | |||
![]() ![]() ![]() |
Whether the Medicinal Product is subject to special measures for regulatory reasons. | |||
![]() ![]() ![]() |
If authorised for pediatric use | |||
![]() ![]() ![]() |
Allows the product to be classified by various systems (e.g. ATC) | |||
![]() ![]() ![]() |
||||
![]() ![]() ![]() ![]() |
Binding: ISO Country two letter code ( preferred ) | |||
![]() ![]() ![]() ![]() |
Status of the marketing of the medicinal product. | |||
![]() ![]() ![]() ![]() |
The date when the Medicinal Product is placed on the market by the Marketing Authorization Holder | |||
![]() ![]() ![]() |
Package type for the product. | |||
![]() ![]() ![]() |
||||
![]() ![]() ![]() ![]() |
Allows the contact to be classified, for example QPPV, Pharmacovigilance Enquiry Information. | |||
![]() ![]() ![]() ![]() |
A specific contact, person (in a role), or an organization for this product | |||
![]() ![]() ![]() |
||||
![]() ![]() ![]() ![]() |
The full product name. | |||
![]() ![]() ![]() ![]() |
Type of product name, such as rINN, Proprietary, Non-Proprietary | |||
![]() ![]() ![]() ![]() |
||||
![]() ![]() ![]() ![]() ![]() |
A fragment of a product name. | |||
![]() ![]() ![]() ![]() ![]() |
Type for this part of the name (e.g. strength part) | |||
![]() ![]() ![]() ![]() |
||||
![]() ![]() ![]() ![]() ![]() |
Country where this name applies | |||
![]() ![]() ![]() ![]() ![]() |
Jurisdiction where this name applies | |||
![]() ![]() ![]() ![]() ![]() |
Language for this name | |||
![]() |
Produced 08 Sep 2023